UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate®

儿童紫绀的病因及评估

Author
Anne M Stack, MD
Section Editor
Stephen J Teach, MD, MPH
Deputy Editor
James F Wiley, II, MD, MPH
Translators
卢慧玲, 副主任医师,副教授

引言

本专题将讨论儿童紫绀的鉴别诊断和处理方法。

背景

紫绀是指毛细血管床血液中还原型血红蛋白浓度增加时皮肤和黏膜出现的蓝紫色改变,多种疾病可引起紫绀,其中很多甚至可危及生命[1]。紫绀最常见于嘴唇、甲床、耳垂、黏膜和其他皮肤较薄的部位。不同的光照条件和肤色可增强或减弱紫绀。危及儿童生命的紫绀大多由呼吸系统疾病引起。

定义

紫绀有两种发生机制:全身动脉血氧饱度下降和以及组织氧摄氧增加。根据这两种发生机制可将紫绀分为两种类型:中心型紫绀和周围型紫绀。此外,一些皮肤问题也可导致类似于紫绀的皮肤蓝色改变,但其毛细血管床血液中的还原型血红蛋白含量并未增加。 (参见下文‘皮肤问题’)

中心型紫绀 — 当全身动脉血中还原型血红蛋白(hemoglobin, Hb)含量超过5g/dL(3.1mmol/L)(血氧饱和度≤85%)时,则会出现中心型紫绀[2]。有一点应注意,若患者有严重贫血[Hb<5g/dL(3.1mmol/L)],则仅凭肉眼观察无法发现紫绀。

周围型紫绀 — 周围型紫绀患者的全身动脉血氧饱和度正常。然而,组织摄氧增加会导致全身动静脉血氧差增大和静脉侧毛细血管内还原型血红蛋白浓度增加。摄氧增加是由毛细血管内血流缓慢引起的。其原因包括血管舒缩功能不稳定、寒冷环境中血管收缩、静脉梗阻、静脉压增大、红细胞增多症和低心输出量。

                              

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: 2017-06 . | This topic last updated: 2015-12-16.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
References
Top
  1. Driscoll DJ. Evaluation of the cyanotic newborn. Pediatr Clin North Am 1990; 37:1.
  2. Grant JB, Saltzman AR. Respiratory functions of the lung. In: Textbook of Pulmonary Diseases, 5th, Baum GL, Wolinsky E. (Eds), Little, Brown, Boston 1994.
  3. DiMaio AM, Singh J. The infant with cyanosis in the emergency room. Pediatr Clin North Am 1992; 39:987.
  4. West JB. Pulmonary gas exchange. In: Physiological Basis of Medical Practice, 12th, West JB. (Ed), Williams & Wilkins, Baltimore 1990. p.546.
  5. Woods WA, McCulloch MA. Cardiovascular emergencies in the pediatric patient. Emerg Med Clin North Am 2005; 23:1233.
  6. Berger S, Konduri GG. Pulmonary hypertension in children: the twenty-first century. Pediatr Clin North Am 2006; 53:961.
  7. Sasidharan P. An approach to diagnosis and management of cyanosis and tachypnea in term infants. Pediatr Clin North Am 2004; 51:999.
  8. Cooke JP, Marshall JM. Mechanisms of Raynaud's disease. Vasc Med 2005; 10:293.
  9. Conlon JD, Drolet BA. Skin lesions in the neonate. Pediatr Clin North Am 2004; 51:863.
  10. Dereure O. Drug-induced skin pigmentation. Epidemiology, diagnosis and treatment. Am J Clin Dermatol 2001; 2:253.
  11. Sweeney SM. Tattoos: a review of tattoo practices and potential treatment options for removal. Curr Opin Pediatr 2006; 18:391.
  12. Fung MC, Bowen DL. Silver products for medical indications: risk-benefit assessment. J Toxicol Clin Toxicol 1996; 34:119.
  13. Dahshan A, Donovan GK. Severe methemoglobinemia complicating topical benzocaine use during endoscopy in a toddler: a case report and review of the literature. Pediatrics 2006; 117:e806.
  14. Wright RO, Lewander WJ, Woolf AD. Methemoglobinemia: etiology, pharmacology, and clinical management. Ann Emerg Med 1999; 34:646.
  15. Stack AM. Cyanosis. In: Textbook of Pediatric Emergency Medicine, 5th, Fleisher GR, Ludwig S, Henretig FM. (Eds), Lippincott Willaims & Wilkins, Philadelphia 2006. p.223.